MedPath

Orion Corporation, Orion Pharma

🇫🇮Finland
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer

Phase 1
Active, not recruiting
Conditions
Prostate Cancer Metastatic
Interventions
First Posted Date
2018-02-19
Last Posted Date
2024-12-20
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
204
Registration Number
NCT03436485
Locations
🇺🇸

University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland, United States

🇺🇸

Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States

🇺🇸

Nebraska Cancer Specialists, Omaha, Nebraska, United States

and more 17 locations

Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva Handihaler

Phase 1
Completed
Conditions
Healthy Subjects
Interventions
First Posted Date
2018-01-17
Last Posted Date
2018-06-14
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
24
Registration Number
NCT03400241
Locations
🇫🇮

Clinical Pharmacology Unit, Espoo, Finland

Impact of Changing the Dosing Regimen on the PK Profile of ODM-203

First Posted Date
2017-08-07
Last Posted Date
2019-05-14
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
16
Registration Number
NCT03240445
Locations
🇬🇧

Quotient Clinical Ltd, Nottingham, United Kingdom

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

Phase 1
Completed
Conditions
Asthma
Interventions
Drug: salmeterol-fluticasone
First Posted Date
2017-08-03
Last Posted Date
2018-04-06
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
64
Registration Number
NCT03238482
Locations
🇫🇮

Clinical Pharmacology Unit, Orion Pharma, Espoo, Finland

Pharmacokinetic of Levodopa Study in Healthy Males

Phase 1
Completed
Conditions
Parkinson Disease
Interventions
Drug: Levodopa, carbidopa, ODM-104
First Posted Date
2017-05-04
Last Posted Date
2017-09-26
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
20
Registration Number
NCT03140956
Locations
🇫🇮

Clinical Pharmacology Unit, Orion Pharma, Espoo, Finland

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Phase 1
Completed
Conditions
Asthma
Interventions
Drug: Budesonide/formoterol
Other: Charcoal
First Posted Date
2017-03-08
Last Posted Date
2017-03-08
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
20
Registration Number
NCT03073057
Locations
🇫🇮

Orion Pharma, Clinical Pharmacology Unit, Espoo, Finland

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus

Phase 1
Completed
Conditions
Asthma
Interventions
Drug: Salmeterol/fluticasone Easyhaler with charcoal
Drug: Seretide Diskus
Drug: Salmeterol/fluticasone Easyhaler
Drug: Seretide Diskus with charcoal
First Posted Date
2017-02-23
Last Posted Date
2017-03-03
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
64
Registration Number
NCT03060044
Locations
🇫🇮

Orion Pharma pharmacology Unit, Espoo, Finland

Dose-finding Pharmacokinetic Study in Healthy Males

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2017-02-16
Last Posted Date
2021-05-27
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
56
Registration Number
NCT03055936
Locations
🇩🇪

Nuvisan Pharma Services, Neu-Ulm, Germany

ODM-207 in Patients With Advance Solid Tumours

Phase 1
Completed
Conditions
Solid Tumors
Interventions
First Posted Date
2017-01-30
Last Posted Date
2019-10-15
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
36
Registration Number
NCT03035591
Locations
🇫🇮

Helsinki University Central Hospital, Department of Oncology, Helsinki, Finland

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)

Phase 2
Completed
Conditions
Parkinson's Disease
Interventions
First Posted Date
2016-05-06
Last Posted Date
2018-04-05
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
84
Registration Number
NCT02764125
Locations
🇫🇮

Clinical Research Services Turku CRST, Turku, Finland

🇩🇪

Study Coordinating Investigator, Harleshausen, Kassel, Germany

🇭🇺

Semmelweis Egyetem Neurológiai Klinika, Budapest, Hungary

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath